We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

179 hedge funds and large institutions have $919M invested in Arcturus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 63 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

12% more capital invested

Capital invested by funds: $820M → $919M (+$98.7M)

8% more funds holding

Funds holding: 165 → 179 (+14)

3.8% more ownership

Funds ownership: 97.34% → 101.13% (+3.8%)

1% less call options, than puts

Call options by funds: $11M | Put options by funds: $11.1M

14% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 63

Holders
179
Holders Change
+14
Holders Change %
+8.48%
% of All Funds
2.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
54
Reduced
63
Closed
18
Calls
$11M
Puts
$11.1M
Net Calls
-$79K
Net Calls Change
+$63K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.9M
2
BlackRock
BlackRock
New York
+$12.2M
3
State Street
State Street
Massachusetts
+$11.7M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.95M

Top Sellers

1
AIM
ARK Investment Management
Florida
-$12.7M
2
Morgan Stanley
Morgan Stanley
New York
-$10.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.59M
4
WP
Woodline Partners
California
-$5.51M
5
GIM
Granahan Investment Management
Massachusetts
-$4.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.44M +$158K +4,456 +2%
UBS AM
27
UBS AM
Illinois
$6.09M +$5.47M +154,444 +595%
Citadel Advisors
28
Citadel Advisors
Florida
$5.64M +$5.91M +166,727 +45,430%
Millennium Management
29
Millennium Management
New York
$5.35M +$881K +24,859 +19%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$5.29M +$1.54M +43,421 +38%
TLP
31
Tri Locum Partners
New York
$4.69M +$1.01M +28,457 +26%
Citigroup
32
Citigroup
New York
$4.61M +$3.1M +87,535 +179%
RA
33
Royce & Associates
New York
$4.45M +$66.7K +1,882 +1%
N
34
Nuveen
North Carolina
$4.18M -$2.51M -70,817 -36%
Arrowstreet Capital
35
Arrowstreet Capital
Massachusetts
$3.94M +$3.37M +95,221 +441%
Connor, Clark & Lunn Investment Management (CC&L)
36
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.92M +$574K +16,203 +16%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.9M -$614K -17,316 -13%
UBS Group
38
UBS Group
Switzerland
$3.65M +$1.25M +35,231 +48%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$3.24M +$1.79M +50,470 +111%
Marshall Wace
40
Marshall Wace
United Kingdom
$2.85M +$2.99M +84,267 New
Neuberger Berman Group
41
Neuberger Berman Group
New York
$2.79M +$2.92M +82,546 New
AQR Capital Management
42
AQR Capital Management
Connecticut
$2.51M -$3.03M -85,648 -54%
Wells Fargo
43
Wells Fargo
California
$2.42M -$46.6K -1,314 -2%
Franklin Resources
44
Franklin Resources
California
$2.39M +$1.94M +54,848 +347%
OAC
45
OMERS Administration Corp
Ontario, Canada
$2.13M – – –
Man Group
46
Man Group
United Kingdom
$2.11M -$847K -23,914 -28%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.91M +$791K +22,317 +65%
Assenagon Asset Management
48
Assenagon Asset Management
Luxembourg
$1.87M +$1.96M +55,237 New
Nordea Investment Management
49
Nordea Investment Management
Sweden
$1.85M +$2.02M +56,931 New
QC
50
Quantedge Capital
Singapore
$1.69M +$1.78M +50,100 New
1
2
3 4 5

ARCT Hedge Fund Activity: Q1 2024 in Review

179 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q1 2024, worth a combined $919M — up 12% from $820M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARCT positions and 18 closed out — a net gain of 15 holders — while 54 added to existing stakes and 63 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $15.9M. The largest seller was ARK Investment Management, cutting an estimated $12.7M.

  • 179 institutional investors held Arcturus Therapeutics (ARCT) as of Q1 2024, up from 165 in Q4 2023.
  • Funds reported $919M of Arcturus Therapeutics stock for Q1 2024, up 12% quarter-over-quarter.
  • 33 funds opened new Arcturus Therapeutics positions in Q1 2024 and 18 closed out, a net change of +15 holders.
  • The largest Arcturus Therapeutics buyer in Q1 2024 was Adage Capital Partners, an estimated $15.9M added.
  • The largest Arcturus Therapeutics seller in Q1 2024 was ARK Investment Management, an estimated $12.7M sold.

Based on aggregated 13F filings for Q1 2024.